← All stocks

Cingulate Inc.

CING Net buying
CIK 0001862150 #4500 in the set updated 19 Sep 2026
Bought (12 mo)
$656.96K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$656.96K
+$656.96K against sales at will

By person

7 insiders · 5 transactions
0.1×

Shane J. Schaffer holds only 0.1 times base salary in stock. $71.83K of shares against $479.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Shane J. Schaffer last reported holding, valued at $5.04, the price Common Stock was last bought or sold at on the open market here, on 13 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Hargroves Thomas Jeffrey
Director
$490.27K (1)
+$490.27K
97,468
$491.24K
+50,665%
Werth Peter J.
Director
$98.05K (1)
+$98.05K
117,449
$591.94K
+19.9%
Schaffer Shane J.
Chief Executive Officer
$34.32K (1)
+$34.32K
14,251
$71.83K
+302.7%
Callahan Jennifer L.
EVP and CFO
$24.51K (1)
+$24.51K
13,961
$70.36K
+7,059%
Brams Matthew
EVP and Chief Medical Officer
$9.81K (1)
+$9.81K
8,157
$41.11K
+201.0%
Silva Raul R.
EVP and CSO
4,645
$23.41K
+138.6%
Patel Nilay Dahyabhai
EVP, CLO and CCO
3,389
$17.08K

No percentages here. This company's share count has moved by a factor of 4.5 over the window, from 3,212,233 to 14,541,826 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Hargroves Thomas Jeffrey
13 Feb 2026
Director
Buy indirect
97,276
$5.04
$490.27K
Brams Matthew
6 Feb 2026
EVP and Chief Medical Officer
Buy
1,946
$5.04
$9.81K
Schaffer Shane J.
6 Feb 2026
Chief Executive Officer
Buy indirect
6,809
$5.04
$34.32K
Callahan Jennifer L.
6 Feb 2026
SVP and CFO
Buy
4,864
$5.04
$24.51K
Werth Peter J.
6 Feb 2026
Director
Buy indirect
19,455
$5.04
$98.05K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 51,043
History held since 9 Dec 2021